WO2003002265A1 - Vernebler zur applikation von flüssigkeiten auf die augenoberfläche oder das augenbindegewebe - Google Patents
Vernebler zur applikation von flüssigkeiten auf die augenoberfläche oder das augenbindegewebe Download PDFInfo
- Publication number
- WO2003002265A1 WO2003002265A1 PCT/EP2002/007042 EP0207042W WO03002265A1 WO 2003002265 A1 WO2003002265 A1 WO 2003002265A1 EP 0207042 W EP0207042 W EP 0207042W WO 03002265 A1 WO03002265 A1 WO 03002265A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nebulizer
- adapter
- eye
- pump
- nozzle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0037—Containers
- B05B11/0039—Containers associated with means for compensating the pressure difference between the ambient pressure and the pressure inside the container, e.g. pressure relief means
- B05B11/0044—Containers associated with means for compensating the pressure difference between the ambient pressure and the pressure inside the container, e.g. pressure relief means compensating underpressure by ingress of atmospheric air into the container, i.e. with venting means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0037—Containers
- B05B11/0039—Containers associated with means for compensating the pressure difference between the ambient pressure and the pressure inside the container, e.g. pressure relief means
- B05B11/0044—Containers associated with means for compensating the pressure difference between the ambient pressure and the pressure inside the container, e.g. pressure relief means compensating underpressure by ingress of atmospheric air into the container, i.e. with venting means
- B05B11/00444—Containers associated with means for compensating the pressure difference between the ambient pressure and the pressure inside the container, e.g. pressure relief means compensating underpressure by ingress of atmospheric air into the container, i.e. with venting means with provision for filtering or cleaning the air flow drawn into the container
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1001—Piston pumps
Definitions
- Nebulizer for applying liquids to the surface of the eye or that
- the present invention relates to nebulizers for applying preservative-free liquids to the cornea or the like
- nebulizers are propellant-free.
- aqueous formulation For the treatment of dry eyes, for moistening the surface of the eyes in contact lens wearers, many eye diseases or examination methods on the eye, medications are usually administered in the form of eye drops in an aqueous formulation.
- Liquid dispensers have been developed for this application form, in which the formulation e.g. is released from a storage bottle via a spout (dropper bottles or EDO ophthiols).
- the aqueous formulation usually flows out of the spout opening due to manual pressure on the compressible storage bottle. A drop then first forms on this, which only tears off the spout at a certain ratio between the size of the spout opening, surface tension and weight of the droplet and then drips into the eye.
- Aqueous eye drops usually have a volume of approx. 0.05 ml.
- Another disadvantage is that the applied formulation is initially only applied to one area of the cornea of the eye, which is not only because of the local pressure on the surface of the eye is felt to be uncomfortable.
- the surface of the eye is coated with a liquid film of approx. 7 microliters.
- Each application of an additional liquid consequently causes part of the total liquid to flow off the eye through the tear duct.
- larger amounts of liquid e.g. Eye drops of 40 microliters and more can be applied.
- a pharmacologically active liquid gets into the tear duct, it can be systemically absorbed by the body, i.e. the pharmacologically active ingredients are absorbed directly by the body. This can lead to allergic or toxicological effects.
- approx. 80% of the amount of liquid applied is displaced from the eye and thus partially reaches the tear duct.
- Another disadvantage is that the patient has to consciously fight against his blink reflex when dripping. If he does not succeed, he does not drip the application formulation onto the eye but the eyelid and he has to drip again, which in turn leads to an overdose with the consequences described above and can cause undesirable systemic side effects.
- Another disadvantage of this method is that there is a brief irritation of the eyes at the dripping point.
- the conventional application devices are also not protected against the penetration of germs into the application formulation, so that preservatives have to be added to the formulations.
- preservatives can lead to chronic inflammation of the connective tissue of the eye or the underlying tenon. This can lead to morphological changes in these tissues, which are particularly disadvantageous during operations, since the wound healing process is hindered and / or scarring can occur.
- US 5588564 discloses a pump spray which is provided with an attachment for applying a spray jet to an eye. Since the spraying time of this system is short, there is a risk that the solution will not be sprayed onto the eyelid but because of the blinking reflex. Neither the pump spray nor the attachment have devices with a germicidal effect.
- US 5921444 discloses a spray device with an attachment for applying a liquid to an eye.
- the disadvantages of this system are similar to those described above.
- WO 96/00050 discloses an applicator for liquids on an eye, in which the spray device is located within a housing, one side of which is designed such that it can encompass an eye.
- the aerosol droplets generated by the device have a diameter of at least 20 micrometers.
- the spraying time of this system is less than 1/20 second (page 13), which has the disadvantages described above.
- EP 0911056 discloses a nebulizer for placement on an eye with an attachment which has a diaphragm or deflection plate which is positioned in such a way that the spray jet does not strike the cornea directly. Such protection is dirty however, on the one hand very quickly and can only be cleaned poorly, on the other hand it prevents exact and reproducible dosing.
- the object of the present invention is to apply aqueous solutions or ophthalmologically active formulations to the surface of the eye in such a way that the local irritation of a site on the cornea is reduced compared to the customary application methods for eye drops.
- Another task is to develop a method with which
- Eye drops can be applied in a way that is more convenient for the user than is known from the prior art.
- Another object is to develop a method in which the liquid to be applied can be applied evenly to the eye.
- Another task is to minimize the risk of injury to the eye when applying the eye drops.
- Another object is to provide an applicator for ophthalmic liquids in which the use of preservatives such as EDTA or benzalkonium chloride in the application solution can be dispensed with.
- the present invention solves this problem by creating nebulizers which transfer the formulation to be applied via a nozzle into a spray cloud with small particle sizes and bring this spray cloud into contact with the surface of the eye, the nebulizers having devices for suppressing nucleation.
- nebulizers have an adapter near the nozzle from which the spray cloud emerges, which fixes the distance between the nozzle and the eye and prevents the spray cloud from being blown away by wind.
- nebulizers can be used as eye applicators, which are equipped with an adapter for guiding the spray cloud to the eye.
- Any type of nebulizer can be used for this purpose, which fulfills the above-mentioned criteria and has devices for preventing the implantation of biological germs in the application solution.
- nebulizers which are known from propellant-free pulmonary inhalation therapy or intranasal use, such as:
- nebulizers which consist of a push-on plastic bottle with a spout
- nebulizers consisting of glass, metal or plastic bottles with pump attachments, preferably those as are known from WO 97/18902, to which reference is hereby made in full
- nebulizers must have devices for preventing nucleation in the storage bottle.
- Such devices include microbiological filters located in the paths through which air can enter the metering chamber or storage bottle. These filters are dimensioned in such a way that they do not let biological germs through, but air.
- Other means include, for example, the application of germicidal or oligodynamic substances to at least part of the above-mentioned airways or to the entire airways. The latter measures are preferred.
- oligodynamically active substances can be used as the material perse. Springs, rods, etc., made of an oligodynamically effective material, can also be hung in the airways.
- Oligodynamic substances are taken to mean metals or metal ions with a germicidal effect. These include, for example, and preferably silver. However, the substances mentioned must be such that they do not irritate or injure the eye, even in the smallest concentration. Nebulizers and / or pump attachments equipped in this way make it possible to dispense with the use of preservatives in the formulations to be applied.
- Preferred nebulizers are those mentioned under point b).
- the nebulization process is triggered by manual actuation of a pump device.
- air can flow into the storage container that has been sterilized beforehand.
- the active substance formulation is preferably under normal pressure, overpressure can be dispensed with.
- the nebulizer should consist of a storage vessel and a pump attachment attached to it.
- the pump attachment preferably has the following features:
- a closure for placing on the storage container which e.g. is designed as a snap, screw or crimp closure;
- a pump channel that can pump liquid from the reservoir into a pressure chamber
- a trigger element via which a piston can be actuated, which builds up the pressure required for nebulization in the pressure chamber;
- An adapter in the form of a cavity with two opposing openings the smaller opening at least the exit point of the aerosol surrounds the nozzle in a coherent manner and the larger opening has a contour that allows this opening to be placed over an eye.
- This type of nebulizer is in no way limiting for the present invention.
- the solution formulations are stored in a reservoir. It is necessary for the active substance formulations used to have sufficient storage stability and, at the same time, to be such that they can be applied directly to the medical purpose, if possible without further manipulation. Furthermore, they must not have any components that can interact with the nebulizer in such a way that the nebulizer or the pharmaceutical quality of the solution or the aerosol produced could be damaged.
- the adapter represents a cavity surrounded by a wall with two openings. One opening surrounds the nozzle in such a way that an emerging one
- Spray jet is directed exclusively into the cavity.
- the nozzle is preferably surrounded in the center by the opening.
- the spray jet leaves the cavity through the second opening, which is generally opposite the first opening, in order to meet the eye.
- the outer contour of the second opening is preferably designed such that it encloses the visible part of the human eye, preferably without directly touching the eye.
- this second opening is preferably of the following shape when the adapter is connected to the nebulizer:
- the openings of the adapter When viewed from above, the openings of the adapter have a round to oval shape.
- the opening facing the eye is shaped so that it completely surrounds the eye, i.e. part of the opening is drawn longer than the other. In cross section, the opening thus presents itself as a concave line, one of which
- the adapter is a funnel-shaped tube with two opposite openings, the opening on the tapering side surrounding the nozzle of the nebulizer and thereby being encased by the adapter through the nozzle opening.
- the opening on the other side of the adapter is so large that it encloses the outer contours of an eye.
- the adapter can be permanently connected to the nebulizer via the first opening, e.g. in which the edge of this opening is welded onto part of the nebulizer or in that the jacket of the nebulizer and the adapter represent a single element.
- the adapter is then an integral part of the nebulizer and this first opening is in fact only a non-open part of the nebulizer.
- the adapter can also be designed as a removable element.
- the side of the adapter connected to the nebulizer can be designed so that it can be placed directly on the nozzle or attached to another element in the vicinity of the nozzle.
- the adapter can be attached to the nozzle of a conventional nebulizer.
- the other end of the adapter is designed so that it can be placed on a person's face in such a way that it completely encloses the visible area of the eye lying in the face and thereby covers as little facial skin as possible. This ensures that the largest part of the spray reaches the surface of the eye without significantly moistening the facial skin.
- the opening of this side of the adapter is preferably oval.
- openings can optionally be formed in the side wall of the adapter, through which excess spray can escape. These openings preferably have a diameter of up to 1 cm, particularly preferably of up to 0.5 cm.
- the adapter is also such that it cannot injure the skin of the face or the eye.
- FIG. 1 A preferred nebulizer (1) with a pump attachment (2) is shown in FIG.
- the pump attachment (2) is firmly connected to the bottle neck (102) of the storage bottle (101) via the snap closure (3).
- This can be made of plastic, glass or metal, for example aluminum, but should be sufficiently rigid that the pump head can be moved without the bottle giving way.
- the inner edge of the snap closure (4) slides over the flange-shaped edge of the bottle neck (102).
- a seal (5) which is designed, for example, from rubber, natural rubber or synthetic rubber or preferably from polyethylene.
- a piston (6) with an axial pump channel (7) is located in the pressure cylinder (8). The piston (6) is held in the upper rest position by the spring (9) at a stop.
- Pressure chamber (10) is connected to the pump channel (7) and is located between the piston (6) and the ball valve (11).
- the piston (6) has a smaller outside diameter than the inside diameter of the pressure cylinder (8), so that a gap (12) remains between the outside wall of the piston and the inside wall of the cylinder, which is sealed by the peripheral sealing body (13) of the piston.
- the pressure cylinder (8) has an area (14) with a larger inside diameter, in which the sealing body (13) has no sealing effect.
- a trigger element (15) is located on the piston (6). From there, a riser pipe (16) leads to a pressure control valve (17) in order to discharge the liquids to be atomized through the opening (18). According to the function, the axial pump channel (7) and the riser pipe (16) form a common riser pipe which connects the pressure chamber to the nozzle.
- the sealing body (13) seals the pressure chamber (10) from the opening (19) of the storage container.
- the plunger (20) is fixed to the piston (6) in the region (21) and has a star-shaped diameter, so that there is a space between the
- oligodynamically active substances are formed along the path that the
- Pump channel (7) be formed in the pressure control valve (17) and / or on the nozzle (18).
- sterility filters To equalize the pressure in the storage container (101) after the discharge of liquids, air can flow into the device from the outside at points (23) and then penetrate into the storage container (101), as shown, for example, by arrow (22) in the Drawing is shown.
- Means for sterilizing the incoming air are formed along the airway. These include, for example, sterility filters, membranes that are only permeable to air, bacteria-retaining materials, oligodynamically active substances, or microbiocidal substances or combinations thereof.
- a sterility filter (24) is shown as an example in FIG.
- the pump attachment (2) is firmly connected to the bottle neck (102) via a snap lock (3).
- the adapter (25) is attached to the trigger element (15) such that the spray jet coming from the nozzle (18) is directed directly into the widened area of the adapter.
- the lower area of the adapter (26) is detachably connected to the trigger element (15).
- the other end of the adapter (27) is designed such that it can be placed on the area around the eyes like a negative.
- the area (14) can pass below the ball valve (11) into a further pump channel, which is only indicated in Fig. 1 (A). This pump channel then opens into the storage vessel.
- the adapter (25) is shown again schematically, the lower region (26) is placed on one or more circular to oval projections in the vicinity of the nozzle or with which it is firmly connected.
- the other end of the adapter which is designed as a negative of the surroundings of the eye, is identified by (27).
- the concave outer contour described above is not shown, as in none of the figures.
- the adapter can be designed in such a way that the momentum of particles of the spray is reduced, in particular by reducing the speed of the particles.
- this is achieved by increasing the distance between the two openings in the adapter.
- nebulizers described above are suitable for nebulizing the ophthalmic aerosol preparations to form an aerosol suitable for application to the eye.
- compositions which can be applied by the nebulizers according to the invention.
- Formulations of this type can also differ from the prior art in that the active compounds may be present in a higher concentration.
- the formulation is merely water (water for injections), or isotonic water or other agents that moisturize the eye. Ie there is no active ingredient.
- Suitable co-solvents include ethanol, polyethylene glycols, polypropylene glycols, ethylene glycols, propylene glycols.
- active ingredients come e.g. Active substances from the group of antibiotics and anti-infectives, anticholinergics, antiglaucomas, antifungals, antiseptics, anesthetics, eye tonics, corticoids and steroids, film formers, vasoactive substances, homeopathic drugs, mydriatics, NSAIDs (anti-inflammatory drugs) and prostagens, vitamins or antioxidants, tear substitutes or viral agents ,
- All pharmacologically and ophthalmically compatible pharmaceutical auxiliaries can also be added to the formulations.
- preservatives such as EDTA, benzalkonium chloride and others can and is preferably dispensed with in the nebulisers according to the invention.
- the advantages of the method according to the invention are, inter alia, that the irritation of the cornea or the connective tissue is reduced in the case of formulations applied to the eye in this way; - Apply ophthalmic formulations evenly on the surface of the eye and thus improve the absorption by the cornea or the connective tissue of the eye;
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002451716A CA2451716A1 (en) | 2001-06-29 | 2002-06-26 | Nebulizer for applying liquids on the surface of the eye or the ocular connective tissue |
EP02745410A EP1404457A1 (de) | 2001-06-29 | 2002-06-26 | Vernebler zur applikation von flüssigkeiten auf die augenoberfläche oder das augenbindegewebe |
JP2003508489A JP2004533888A (ja) | 2001-06-29 | 2002-06-26 | 目の表面又は結膜組織に液体を塗布する噴霧器 |
US10/739,484 US20040164099A1 (en) | 2001-06-29 | 2003-12-18 | Nebulizer for applying liquids on the surface of the eye or the ocular connective tissue |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10131174.5 | 2001-06-29 | ||
DE10131174A DE10131174A1 (de) | 2001-06-29 | 2001-06-29 | Vernebler zur Applikation von Flüssigkeiten auf die Augenoberfläche oder das Augenbindegewebe |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003002265A1 true WO2003002265A1 (de) | 2003-01-09 |
Family
ID=7689759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/007042 WO2003002265A1 (de) | 2001-06-29 | 2002-06-26 | Vernebler zur applikation von flüssigkeiten auf die augenoberfläche oder das augenbindegewebe |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040164099A1 (de) |
EP (1) | EP1404457A1 (de) |
JP (1) | JP2004533888A (de) |
CA (1) | CA2451716A1 (de) |
DE (1) | DE10131174A1 (de) |
WO (1) | WO2003002265A1 (de) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7883031B2 (en) | 2003-05-20 | 2011-02-08 | James F. Collins, Jr. | Ophthalmic drug delivery system |
US8684980B2 (en) | 2010-07-15 | 2014-04-01 | Corinthian Ophthalmic, Inc. | Drop generating device |
US8733935B2 (en) | 2010-07-15 | 2014-05-27 | Corinthian Ophthalmic, Inc. | Method and system for performing remote treatment and monitoring |
US9087145B2 (en) | 2010-07-15 | 2015-07-21 | Eyenovia, Inc. | Ophthalmic drug delivery |
US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
EP2152341B1 (de) * | 2007-05-15 | 2019-12-11 | Boehringer Ingelheim Pharma GmbH & Co. KG | Zerstäuber in form eines inhalators zur medizinischen aerosol-therapie |
US10639194B2 (en) | 2011-12-12 | 2020-05-05 | Eyenovia, Inc. | High modulus polymeric ejector mechanism, ejector device, and methods of use |
US11938056B2 (en) | 2017-06-10 | 2024-03-26 | Eyenovia, Inc. | Methods and devices for handling a fluid and delivering the fluid to the eye |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4795637B2 (ja) | 2001-09-28 | 2011-10-19 | カーブ テクノロジー,インコーポレイティド | 鼻ネブライザー |
WO2003099359A1 (en) | 2002-05-09 | 2003-12-04 | Kurve Technology, Inc. | Particle dispersion chamber for nasal nebulizer |
US8012136B2 (en) | 2003-05-20 | 2011-09-06 | Optimyst Systems, Inc. | Ophthalmic fluid delivery device and method of operation |
US20070131230A1 (en) * | 2003-09-05 | 2007-06-14 | Kurve Technology, Inc. | Nasal adapter for the base of the nose |
EP1673123A2 (de) * | 2003-09-05 | 2006-06-28 | Kurve Technology, Inc. | Integrierter vernebler und teilchendispersionskammer zur abgabe eines medikaments |
DE102004048503A1 (de) * | 2004-10-05 | 2006-04-13 | Thilo Schleip | Vorrichtung zur Benetzung von Kontaktlinsen im Auge |
WO2006082588A2 (en) * | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
DE102005029746B4 (de) * | 2005-06-24 | 2017-10-26 | Boehringer Ingelheim International Gmbh | Zerstäuber |
US7905229B2 (en) * | 2006-08-30 | 2011-03-15 | Kurve Technology, Inc. | Aerosol generating and delivery device |
US8034036B2 (en) * | 2007-04-10 | 2011-10-11 | Tom Osborne | Portable eye flushing system and method |
US9981041B2 (en) | 2016-08-23 | 2018-05-29 | Ira Jason Salzman | Ophthalmic lubricating spray |
US10893977B2 (en) * | 2017-01-17 | 2021-01-19 | Omera Medical, Inc. | Device and method to treat eye conditions, eyelids conditions, or both |
CN109224213B (zh) * | 2018-08-30 | 2021-01-22 | 黄劲鹏 | 一种防眼部干燥的眼部湿润器 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000050A1 (en) | 1994-06-23 | 1996-01-04 | R.P. Scherer Corporation | Ocular treatment device |
US5588564A (en) | 1995-08-21 | 1996-12-31 | Hutson; Clifford L. | Eye spray mist dispenser |
WO1997018902A1 (de) * | 1995-11-17 | 1997-05-29 | Ursatec Verpackung-Gmbh | Vor kontamination schützende abgabevorrichtung für fluide |
EP0911056A1 (de) | 1997-10-21 | 1999-04-28 | The Mentholatum Company Limited | Augenanwendungsvorrichtung |
US5921444A (en) | 1994-08-05 | 1999-07-13 | Ing. Erich Pfeiffer Gmbh | Dispenser providing treatment surface engagement |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314426A (en) * | 1964-05-20 | 1967-04-18 | Lever Brothers Ltd | Eyecup and spray dispenser |
BE788194A (fr) * | 1971-08-31 | 1973-02-28 | Thomae Gmbh Dr K | Dispositif pour l'administration de quantites mecaniquement dosees de medicaments liquides ou en solution |
US3841533A (en) * | 1972-11-24 | 1974-10-15 | Schmid Lab | Spray dispenser and shield |
DE3315334A1 (de) * | 1983-04-28 | 1984-10-31 | Pfeiffer Erich Gmbh & Co Kg | Zerstaeuber- oder dosierpumpe |
US4733802A (en) * | 1986-11-05 | 1988-03-29 | Sheldon Gerald M | Eye drop dispensing system |
US5037406A (en) * | 1988-06-20 | 1991-08-06 | Smith William L | Eyedrop applicator attachment |
DE4027320C2 (de) * | 1990-08-29 | 1993-09-30 | Ursapharm Arzneimittel Gmbh | Fluid-Abgabeeinrichtung für keimfreies Fluid |
DE4400944A1 (de) * | 1994-01-14 | 1995-07-20 | Ursatec Verpackung Gmbh | Saug-Druckpumpe für Fluidbehälter |
US5578021A (en) * | 1995-10-05 | 1996-11-26 | Cornish; Brian K. | Eye medicament dispensing device |
ES2190477T3 (es) * | 1995-11-17 | 2003-08-01 | Ursatec Verpackung Gmbh | Dispensador de fluidos diseñado para proteger el contenido de la contaminacion. |
DE19622124A1 (de) * | 1996-06-01 | 1997-12-04 | Alfred Von Schuckmann | Gerät zum Aufbringen von Flüssigkeiten |
DE19742559C2 (de) * | 1997-09-26 | 1999-08-05 | Gaplast Gmbh | Behälter mit Pumpe |
-
2001
- 2001-06-29 DE DE10131174A patent/DE10131174A1/de not_active Withdrawn
-
2002
- 2002-06-26 EP EP02745410A patent/EP1404457A1/de not_active Withdrawn
- 2002-06-26 CA CA002451716A patent/CA2451716A1/en not_active Abandoned
- 2002-06-26 JP JP2003508489A patent/JP2004533888A/ja active Pending
- 2002-06-26 WO PCT/EP2002/007042 patent/WO2003002265A1/de not_active Application Discontinuation
-
2003
- 2003-12-18 US US10/739,484 patent/US20040164099A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000050A1 (en) | 1994-06-23 | 1996-01-04 | R.P. Scherer Corporation | Ocular treatment device |
US5921444A (en) | 1994-08-05 | 1999-07-13 | Ing. Erich Pfeiffer Gmbh | Dispenser providing treatment surface engagement |
US5588564A (en) | 1995-08-21 | 1996-12-31 | Hutson; Clifford L. | Eye spray mist dispenser |
WO1997018902A1 (de) * | 1995-11-17 | 1997-05-29 | Ursatec Verpackung-Gmbh | Vor kontamination schützende abgabevorrichtung für fluide |
EP0911056A1 (de) | 1997-10-21 | 1999-04-28 | The Mentholatum Company Limited | Augenanwendungsvorrichtung |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8936021B2 (en) | 2003-05-20 | 2015-01-20 | Optimyst Systems, Inc. | Ophthalmic fluid delivery system |
US7883031B2 (en) | 2003-05-20 | 2011-02-08 | James F. Collins, Jr. | Ophthalmic drug delivery system |
EP2152341B1 (de) * | 2007-05-15 | 2019-12-11 | Boehringer Ingelheim Pharma GmbH & Co. KG | Zerstäuber in form eines inhalators zur medizinischen aerosol-therapie |
US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
US9087145B2 (en) | 2010-07-15 | 2015-07-21 | Eyenovia, Inc. | Ophthalmic drug delivery |
US10073949B2 (en) | 2010-07-15 | 2018-09-11 | Eyenovia, Inc. | Ophthalmic drug delivery |
US8733935B2 (en) | 2010-07-15 | 2014-05-27 | Corinthian Ophthalmic, Inc. | Method and system for performing remote treatment and monitoring |
US8684980B2 (en) | 2010-07-15 | 2014-04-01 | Corinthian Ophthalmic, Inc. | Drop generating device |
US10839960B2 (en) | 2010-07-15 | 2020-11-17 | Eyenovia, Inc. | Ophthalmic drug delivery |
US11011270B2 (en) | 2010-07-15 | 2021-05-18 | Eyenovia, Inc. | Drop generating device |
US11398306B2 (en) | 2010-07-15 | 2022-07-26 | Eyenovia, Inc. | Ophthalmic drug delivery |
US11839487B2 (en) | 2010-07-15 | 2023-12-12 | Eyenovia, Inc. | Ophthalmic drug delivery |
US10639194B2 (en) | 2011-12-12 | 2020-05-05 | Eyenovia, Inc. | High modulus polymeric ejector mechanism, ejector device, and methods of use |
US10646373B2 (en) | 2011-12-12 | 2020-05-12 | Eyenovia, Inc. | Ejector mechanism, ejector device, and methods of use |
US11938056B2 (en) | 2017-06-10 | 2024-03-26 | Eyenovia, Inc. | Methods and devices for handling a fluid and delivering the fluid to the eye |
Also Published As
Publication number | Publication date |
---|---|
EP1404457A1 (de) | 2004-04-07 |
JP2004533888A (ja) | 2004-11-11 |
US20040164099A1 (en) | 2004-08-26 |
CA2451716A1 (en) | 2003-01-09 |
DE10131174A1 (de) | 2003-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1408899A1 (de) | Vernebler zur aufbringung von flüssigkeiten auf die augenhornhaut | |
WO2003002265A1 (de) | Vernebler zur applikation von flüssigkeiten auf die augenoberfläche oder das augenbindegewebe | |
DE69625408T2 (de) | Doppelfluidabgabeeinrichtung für Wirkstoffflüssigkeiten | |
DE69725161T2 (de) | Pharmazeutische zusammensetzung auf wasserbasis | |
DE69511102T2 (de) | Wiederbelebungsgerät | |
EP1509266B1 (de) | System umfassend eine düse und ein halterungssystem | |
DE60027714T3 (de) | Zerstäubungssystem mit niedriger spraykraft und retention | |
DE60225273T2 (de) | Gesichtsmasken für druckbetriebene Arzneiverabreichungssysteme | |
US20090182291A1 (en) | Eye medicament dispenser | |
EP1332004A1 (de) | Zerstäuber für flüssigkeiten | |
DE60130638T2 (de) | Atmungsbetätigter inhalator | |
DE2101874A1 (de) | Zerstäuber | |
DE20307306U1 (de) | Medizinischer, mechanischer Kompressorzerstäubungsapparat | |
DE69828275T2 (de) | Flüssigkeitsapplikator für die augen | |
EP0170198B1 (de) | Spender zur intranasalen Applikation von Flüssigkeiten in Form von Sprays oder Tropfen | |
US8133210B2 (en) | Aqueous ophthalmic spray and method for delivery of artificial tears to the ocular surface | |
EP3323455B1 (de) | Inhalationseinrichtung zum zwecke des inhalierens eines tröpfchennebels | |
DE202013010261U1 (de) | Konservierungsmittelfreie pharmazeutische Zusammensetzungen für die ophthalmische Verabreichung | |
DE202013000774U1 (de) | Miniaturisiertes Inhalationsgerät zur Privatanwendung | |
DE102007020578A1 (de) | Wässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole | |
DE10241640A1 (de) | Dosierinhalationsgerät, hierzu geeigneter Behälter, und System aus Dosierinhalationsgerät und Behälter | |
WO2020200830A1 (de) | Einstellbarer aerosoldispenser für ein beatmungsgerät und beatmungsgerät mit demselben | |
CH708839B1 (de) | Konservierungsmittelfreie pharmazeutische Zusammensetzungen für die ophthalmische Verabreichung. | |
DE20209725U1 (de) | Pumpzerstäuber | |
DE102009019491A1 (de) | Vorrichtung zur Applikation von Arzneizubereitungen am Auge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002745410 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2451716 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003508489 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002745410 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004110945 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002745410 Country of ref document: EP |